Covered recipient · General Payments record
RAJAT GUPTA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$86,482.73
- Reported across 452 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $985.84 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $410.09 | 4 |
| ABBVIE INC. | $239.46 | 7 |
| TG THERAPEUTICS, INC. | $180.36 | 2 |
| Lundbeck LLC | $100.72 | 2 |
| Axsome Therapeutics, Inc. | $55.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.16 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980303 | CMS |
| ABBVIE INC. | $33.10 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980305 | CMS |
| ABBVIE INC. | $108.65 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980307 | CMS |
| ABBVIE INC. | $10.80 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980309 | CMS |
| ABBVIE INC. | $25.77 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980311 | CMS |
| ABBVIE INC. | $9.46 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980313 | CMS |
| ABBVIE INC. | $23.52 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201980315 | CMS |
| Axsome Therapeutics, Inc. | $55.21 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235492498 | CMS |
| Lundbeck LLC | $20.00 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251801448 | CMS |
| Lundbeck LLC | $80.72 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251801450 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.93 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247362766 | CMS |
| Teva Pharmaceuticals USA, Inc. | $117.22 | 01/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247362784 | CMS |
| Teva Pharmaceuticals USA, Inc. | $138.59 | 06/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247362852 | CMS |
| Teva Pharmaceuticals USA, Inc. | $139.35 | 10/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247362910 | CMS |
| TG Therapeutics, Inc. | $116.25 | 02/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226223497 | CMS |
| TG Therapeutics, Inc. | $64.11 | 02/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226223505 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.